Published on ASSET (http://www.asset-scienceinsociety.eu)

Home > Glossary > Glossary

Glossary

A (34) | B (20) | C (59) | D (17) | E (40) | F (13) | G (26) | H (21) | I (28) | K (1) | L (8) | M (21) | N (8) | O (6) | P (42) | Q (3) | R (18) | S (53) | T (14) | U (9) | V (21) | W (3) | Z (1)
Definitionssort descending Last update
Absolute risk reduction (risk difference, excess risk) 26/05/2015
Accountability 23/06/2015
Acculturation 23/06/2015
Acquired immunity 23/06/2015
Active listening 23/06/2015
Active public 23/06/2015
Acute 22/06/2015
Acute disease 23/06/2015
Ad hominem 23/06/2015
Adjuvant 22/06/2015
Adverse effect 22/06/2015
Aerosol 22/06/2015
Age-adjusted mortality rate 23/06/2015
Age-specific mortality rate 22/06/2015
Agenda-setting 23/06/2015
Agent based social simulation system 23/06/2015
Airway 22/06/2015
Alert phase 23/06/2015
Alert threshold 22/06/2015
Anthrax 22/06/2015
Antibody 22/06/2015
Antigenic drift 24/06/2015
Antigenic shift 24/06/2015
Antimicrobial resistance (AMR) 22/06/2015
Antitoxin 22/06/2015
Antiviral agent (antiviral, antiviral drug) 24/06/2015
Argumentum ad populum 22/06/2015
Assessment 22/06/2015
Asynchronous communication 23/06/2015
Attack rate 22/06/2015
Attitude(s) 23/06/2015
Audience 23/06/2015
Autonomy 22/06/2015
Avian influenza (bird flu) 23/06/2015

Newsletters

Select the newsletter(s) to which you want to subscribe or unsubscribe.

News from Asset project
Responsible Research and Innovation Newsletter
Asset PPRB
E-mail *

Contacts

Contacts

General inquiries: info@asset-scienceinsociety.eu

ASSET

Action plan on Science in Society related issues in Epidemics and Total pandemics
European Commission
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236.
Source URL: http://www.asset-scienceinsociety.eu/outputs/glossary